Richard J. Zeifman, MA, is affiliated with the Department of Medicine at Imperial College London and the Department of Psychology at Ryerson University. His publications focus on the clinical effects of psychedelic therapy, specifically examining its impact on suicidality through meta-analyses of individual patient data from clinical trials. His work contributes to the understanding of psychedelics in psychiatric treatment and suicide prevention.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
